BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 20038811)

  • 21. Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo.
    Han L; Wang W; Fang Y; Feng Z; Liao S; Li W; Li Y; Li C; Maitituoheti M; Dong H; Lai Z; Gao Q; Xi L; Wu M; Wang D; Zhou J; Meng L; Wang S; Ma D
    J Immunol; 2009 Dec; 183(12):7842-50. PubMed ID: 19923459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
    Speiser DE; Liénard D; Rufer N; Rubio-Godoy V; Rimoldi D; Lejeune F; Krieg AM; Cerottini JC; Romero P
    J Clin Invest; 2005 Mar; 115(3):739-46. PubMed ID: 15696196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.
    Flynn R; Hutchinson T; Murphy KM; Ware CF; Croft M; Salek-Ardakani S
    PLoS One; 2013; 8(10):e77991. PubMed ID: 24205056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
    Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
    J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
    Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
    J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion.
    Zhang Y; Ertl HC
    J Immunol; 2014 Aug; 193(4):1836-46. PubMed ID: 25024391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
    Appay V; Jandus C; Voelter V; Reynard S; Coupland SE; Rimoldi D; Lienard D; Guillaume P; Krieg AM; Cerottini JC; Romero P; Leyvraz S; Rufer N; Speiser DE
    J Immunol; 2006 Aug; 177(3):1670-8. PubMed ID: 16849476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.
    Speiser DE; Baumgaertner P; Barbey C; Rubio-Godoy V; Moulin A; Corthesy P; Devevre E; Dietrich PY; Rimoldi D; Liénard D; Cerottini JC; Romero P; Rufer N
    J Immunol; 2006 Jul; 177(2):1338-48. PubMed ID: 16818795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
    Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
    Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
    J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
    Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
    Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
    Valmori D; Dutoit V; Ayyoub M; Rimoldi D; Guillaume P; Liénard D; Lejeune F; Cerottini JC; Romero P; Speiser DE
    Cancer Immun; 2003 Oct; 3():15. PubMed ID: 14580186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
    Ahmadzadeh M; Johnson LA; Heemskerk B; Wunderlich JR; Dudley ME; White DE; Rosenberg SA
    Blood; 2009 Aug; 114(8):1537-44. PubMed ID: 19423728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.